Skip to content
Search

Latest Stories

GASTRO: Improving your patients’ gut health

Joshua Edwards shares five practical tips for pharmacy teams to support patients who have problems with their digestive system or gut health...

Gut microbiome is the combined genetic material (genomes) of the microorganisms residing in the gut. The term microbiota is used to describe the community of microorganisms themselves.


Lower microbiota diversity indicates a microbial imbalance within the gut, and is often found in people with autoimmune diseases, obesity and cardiometabolic conditions.

Studies have found that while there is a heritable component to gut microbiota, the role of environmental factors such as diet, drugs and anthropometric measures play a key role in one’s microbiota composition. Pharmacy teams are best placed to advise their patients on ways to improve their gut heath.

Popular media suggests the key to solving all health problems is to nurture the gut through drinking kombucha and avoiding gluten. But how true is this really? Ask your patients to consider implementing the following five tips, informed by scientific literature, into their diet and lifestyle, to improve the microbiota diversity.

Foods to avoid

First thing: avoid consuming high intensity sweeteners, like sucralose and aspartame. While sugar alternatives like sucralose, aspartame and saccharin are generally considered safe by regulatory bodies, studies have shown these sugar substitutes disrupt the balance and diversity of gut microbiota.

Researchers investigated the impact of non-nutritive sweeteners, including aspartame, saccharin, stevia, sucralose, alongside control groups, and found that all four of the tested sweeteners altered the bacteria in the gut and the molecules they secrete. Additionally, all four were seen to “distinctly impact” the oral microbiome of the person consuming them.

Such microbiome changes did not occur in the control groups, which suggest that the consumption of high intensity sweeteners may not be much better for our health than the consumption of sugar, which has been linked to health conditions like obesity and diabetes.

More recently, a study found that a new low-calorie sweetener promotes the growth of beneficial gut bacteria, which impacts overall health.

Drug interaction

Encourage your patients to have a conversation with you about medications that could be interacting with their gut microbiota. Diet is not the only factor that could impact on the health of gut microbiota, and medication has also been seen to play a key role in modulating the gut microbiota composition.

For example, antibiotics, which even when studying short-term courses, have been shown to decrease the taxonomic richness, diversity and reduce the colonized resistance from invading pathogens.

A large Dutch-Belgian population study found that drugs had the largest explanatory power on microbiota composition. Further studies have shown the major impact of commonly prescribed proton pump inhibitors on the microbial community, which may explain the higher rates of gastrointestinal infection seen in people taking these drugs. This may result in an alternative being chosen that is less likely to impact gut microbiota.

Probiotic supplements

Another good idea is to supplement with probiotics for various health benefits. Probiotics are live bacteria and yeasts that, if administered in a viable form and adequate amount, have beneficial effects on our overall health. Probiotics, like Bifidobacterium and Lactobacillus, can be added to yoghurts, taken as food supplements and even added to drugs.

The therapeutic effect of probiotic supplementation has been studied in a broad range of diseases. They can affect health independently of the gut microbiota through direct effects on the host, such as through immune modulation or the production of bioactive compounds.

Plant-based diet

There is merit in a shift towards a plant-based diet for better delivery of beneficial metabolites. Changes to the gut microbiota can occur within days of changing diet, and studies have shown a plant-based diet can increase the delivery of beneficial metabolites, produced by bacteria, like equol, whilst decreasing the production of harmful metabolites such as trimethylamine.

In the plasma metabolome of people eating a vegan diet, positive bacterial metabolites were more abundant while lipid and amino acid metabolites were less abundant, which may provide a health benefit compared to people eating a diet inclusive of meat.

If your patients eat a diet heavy in meat and dairy, you might want to ask them to consider reducing their consumption of these food types and incorporating more fresh fruit and vegetables, which are high in fibre to improve their gut health.

But they should incorporate less meat and more fibre gradually, because studies have shown that major increases in dietary fibre can temporarily reduce diversity, as the microbes that digest fibre become specifically enriched.

Individual sensitivities

Studies have found that glutenfree bread reduces the microbiota imbalance experienced by the people with gluten sensitivity or coeliac disease. However, studies have also shown that for people who do not have coeliac disease or an intolerance to gluten, avoiding gluten showed a reduced abundance of beneficial microbes and may lead to an increased risk of heart diseases, potentially due to a reduced consumption of key whole grains needed for healthy gut microbiota.

So before they restrict consumption of gluten, advise them to speak yourself or their GP about testing for an intolerance or sensitivity to the protein to be sure they are taking the right steps to improve their gut health.

(Joshua Edwards is a Pilltime pharmacist.)

More For You

Samson Akere with the Totty Pharmacy team

Samson Akere with the Totty Pharmacy team

“Team work makes dream work”

Winning Team of the Year at the Pharmacy Business Awards, just one year after opening, is a reflection of the exceptional leadership Totty Pharmacy owner Samson Akere displayed to ensure his first foray into ownership was a success.

Akere took over the pharmacy in Charlton in October 2023 and straight away he set out on the path to create a diverse, multi-skilled team.

Keep ReadingShow less
Humanin Peptide: A Mitochondrial-Derived Factor with Potential Implications for Cellular Research

Humanin Peptide: A Mitochondrial-Derived Factor with Potential Implications for Cellular Research

Humanin is a mitochondrial-derived peptide (MDP) that has garnered interest due to its potential roles in cellular homeostasis, stress resistance, and metabolic regulation. Initially discovered in relation to neuroprotection, this small peptide has since been hypothesized to interact with multiple cellular pathways, suggesting its involvement in broader physiological processes. Given its origin from mitochondrial DNA (mtDNA), Humanin is believed to be a key player in mitochondrial communication with the nucleus and other cellular compartments, potentially impacting various research fields, including cellular aging, metabolic regulation, and cellular stress response.

Molecular Characteristics and Mechanisms

Keep ReadingShow less
The Realities of Dementia Care for Families

The Realities of Dementia Care for Families

Caring for a loved one with dementia is a journey that presents both emotional and practical challenges for families. Dementia, a progressive condition affecting memory, cognition, and behaviour, requires long-term care strategies and significant emotional resilience. Understanding the realities of dementia care can help families prepare and ensure their loved ones receive the best possible support.

1. The Emotional Toll on Families

Keep ReadingShow less
The UK Commission on Pharmacy Professional Leadership’s report outlined three potential pathways for the future of pharmacy leadership
UKPPLAB aims to enable greater collaboration across the pharmacy professional leadership bodies (gettyimages)

Exclusive: Pharmacy leaders have the opportunity to "co-create the future” with greater collaboration

By Sarwar Alam

Pharmacy leaders from across the sector need to work together in order to have a stronger voice in the future of the healthcare system, Sir Hugh Taylor, chair of the UK Pharmacy Professional Leadership Advisory Board (UKPPLAB), has told Pharmacy Business.

Keep ReadingShow less
Pharmacy First: Workforce capacity continues to be a concern
Community pharmacies in England delivered 2 million Pharmacy First consultations in the first year alone (gettyimages)

Pharmacy First needs proper support to reach its full potential: Numark

Sector needs a remuneration model that ensures pharmacies are not just delivering Pharmacy First service, but thriving while doing so 

Pharmacy First has demonstrated the enormous value of community pharmacy in providing accessible front-line care. However, pharmacists continue to face several challenges in delivering the service.

“Pharmacy First is a success, but it needs proper support to reach its full potential,” said Numark chairman Harry McQuillan.

Keep ReadingShow less